Net Cash Provided by (Used in) Operating Activities |
145M |
USD |
+6.71% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-69.4M |
USD |
-40.1% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-263K |
USD |
+97.2% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
94.9M |
shares |
-5.29% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
75M |
USD |
-2.07% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
944M |
USD |
-2.31% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
17.9M |
USD |
+5.75% |
Mar 31, 2022 |
Q1 2022 |
Deferred Tax Assets, Valuation Allowance |
3.4M |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
83.4M |
USD |
-0.92% |
Dec 31, 2023 |
Q4 2023 |
Operating Lease, Liability |
78M |
USD |
+0.75% |
Mar 31, 2024 |
Q1 2024 |
Payments to Acquire Property, Plant, and Equipment |
6.42M |
USD |
-1.29% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-3.15M |
USD |
-114% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
-5.93M |
USD |
-167% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
121M |
USD |
-28% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
23.9M |
USD |
-9.96% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
97.4M |
USD |
-31.4% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
7.33M |
USD |
+3.87% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
80.1M |
USD |
-0.91% |
Dec 31, 2023 |
Q4 2023 |
Share-based Payment Arrangement, Expense |
22.7M |
USD |
+30.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
2.78M |
USD |
-79.3% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |